(Q52372494)

30 April 2018

title

Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: need for controlled trials. (English)

1 reference

30 April 2018

main subject

phase II clinical trial

0 references

hepatocellular carcinoma

1 reference

1

1 reference

30 April 2018

Antoni Castells

2

1 reference

30 April 2018

Xavier Calvet

4

1 reference

30 April 2018

Xavier Calvet

5

1 reference

30 April 2018

Lluís Jover

8

1 reference

30 April 2018

author name string

Montanyà X

3

1 reference

30 April 2018

Brú C

6

1 reference

30 April 2018

Ayuso C

7

1 reference

30 April 2018

García L

9

1 reference

30 April 2018

Vilana R

10

1 reference

30 April 2018

Boix L

11

1 reference

30 April 2018

language of work or name

English

0 references

publication date

1 September 1994

1 reference

30 April 2018

published in

Hepatology

1 reference

30 April 2018

volume

20

1 reference

30 April 2018

issue

3

1 reference

30 April 2018

page(s)

643-650

1 reference

30 April 2018

Transcatheter embolization of hepatocellular carcinoma: assessment of efficacy in cases of resection following embolization

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

Peripheral hepatic artery embolization for primary and secondary hepatic neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

NIH conference. Hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

Histologic assessment of resected hepatocellular carcinoma after transcatheter hepatic arterial embolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

7 January 2021

Hepatic artery embolization for inoperable hepatocellular carcinoma; prognosis and risk factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

7 January 2021

Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

7 January 2021

Hepatic artery embolization in 120 patients with unresectable hepatoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

7 January 2021

A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

7 January 2021

Use of a prognostic index in evaluation of liver transplantation for primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

7 January 2021

Efficacy of liver transplantation in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

7 January 2021

Survival after liver transplantation of patients with primary biliary cirrhosis in the Nordic countries. Comparison with expected survival in another series of transplantations and in an international trial of medical treatment.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

7 January 2021

Confidence intervals for reporting results of clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

7 January 2021

Confidence intervals for the survival function using Cox's proportional-hazard model with covariates

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

7 January 2021

Hepatic arterial chemotherapy and occlusion for palliation of primary hepatocellular and unknown primary neoplasms in the liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

7 January 2021

Chemoembolization for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

7 January 2021

A simple method for biliary-enteric anastomosis and chronic bile diversion in the rat.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

7 January 2021

Non-operative arterial embolisation in primary liver tumours

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

7 January 2021

Therapeutic embolisation of the hepatic artery: a review of 75 procedures

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

7 January 2021

Prognostic factors in patients with hepatocellular carcinoma. Attempts for the selection of patients with prolonged survival

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

7 January 2021

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

7 January 2021

Compensated cirrhosis: Natural history and prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

7 January 2021

Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the Cox proportional hazard model

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

7 January 2021

Clinical trials in primary hepatocellular carcinoma: current status and future directions

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

7 January 2021

Intraarterial adriamycin and lipiodol for inoperable hepatocellular carcinoma: a comparison with intravenous adriamycin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200315

7 January 2021

Identifiers

DOI

10.1002/HEP.1840200315

1 reference

30 April 2018

PubMed ID

7521316

1 reference

30 April 2018